Skip to main content
Signal8
Azar Alex M II profile photo

Alex M. Azar II

CIK: 0001402256

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Guardant Health, Inc. logo
GH

Guardant Health, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Guardant Health, Inc. logo
    GH

    Guardant Health, Inc.

    Oct 14, 2026
    Sale(S)
    Direct
    69 shares at avg. $159.89$11K
  • Guardant Health, Inc. logo
    GH

    Guardant Health, Inc.

    Oct 12, 2026
    Exercise(M)
    Direct
    137 shares-
  • Guardant Health, Inc. logo
    GH

    Guardant Health, Inc.

    Sep 16, 2026
    Sale(S)
    Direct
    826 shares at avg. $175.00$145K
  • Guardant Health, Inc. logo
    GH

    Guardant Health, Inc.

    Sep 12, 2026
    Exercise(M)
    Direct
    1.7K shares-
  • Guardant Health, Inc. logo
    GH

    Guardant Health, Inc.

    Jun 17, 2026
    Award(A)

    Restricted Stock Units

    Direct
    2.7K shares-
  • Guardant Health, Inc. logo
    GH

    Guardant Health, Inc.

    Sep 12, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    10.5K shares-
  • Guardant Health, Inc. logo
    GH

    Guardant Health, Inc.

    Sep 12, 2025
    Award(A)

    Restricted Stock Units

    Direct
    6.6K shares-

1-7 of 7

About Azar Alex M II

Azar Alex M II (SEC CIK 0001402256) files insider reports with the SEC as Director of Guardant Health, Inc. (GH).

Signal8 holds 7 ownership filings by Azar Alex M II (1 Form 3, 6 Form 4), filed between Sep 26, 2025 and Oct 15, 2026. Those filings report 7 transactions, from Sep 12, 2025 to Oct 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Azar Alex M II's filings is in PALO ALTO, CA.

Recent filings by Azar Alex M II

  • Oct 14, 2026: Open-market sale of GH shares (Form 4, code S).
  • Oct 12, 2026: Option exercise of GH shares (Form 4, code M).
  • Sep 16, 2026: Open-market sale of GH shares (Form 4, code S).
  • Sep 12, 2026: Option exercise of GH shares (Form 4, code M).
  • Jun 17, 2026: Grant or award of GH derivative securities (Form 4, code A).

Other insiders filing for Guardant Health, Inc. (GH)

How to read Form 4 transaction codes